VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Marsh & McLennan Companies, Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Marsh & McLennan Companies, Inc.
MMC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Marsh & McLennan Companies, Inc.'s moat claims, evidence, and risks.
View MMC analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 65 / 100 for Marsh & McLennan Companies, Inc.).
- Segment focus: Marsh & McLennan Companies, Inc. has 2 segments (62.8% in Risk and Insurance Services); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Marsh & McLennan Companies, Inc. has 5 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Marsh & McLennan Companies, Inc.
Risk and Insurance Services
Insurance brokerage, risk advisory, and reinsurance brokerage/services
Global
Enterprises, public entities, associations, and individuals (via broker/agent channels)
Intermediary + advisor (insurance/reinsurance market intermediary)
62.8%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Marsh & McLennan Companies, Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Marsh & McLennan Companies, Inc. segments
Full profile >Risk and Insurance Services
Oligopoly
Consulting
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.